stockrowIntuitive Surgical, Inc.
ISRG Healthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024.
- Revenue
- +21.7%
- EPS
- −24.2%
- Free cash flow
- +51.0%
Quarter to September 2026, against a year earlier
Follow ISRG
Alert me
Intuitive Surgical, Inc. (ISRG) Return on assets
Intuitive Surgical, Inc.'s return on assets over the twelve months to 30 September 2026 was 15.3%, up 0.7 percentage points from fiscal 2025 (14.6%). Over the past ten years it has ranged from 9.97% (fiscal 2022) to 16.6% (fiscal 2018); the current reading is higher than 82% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 14.6% | 0.98 |
| FY2024 | 13.6% | 0.93 |
| FY2023 | 12.7% | 2.69 |
| FY2022 | 9.97% | (3.82) |
| FY2021 | 13.8% | 3.64 |
| FY2020 | 10.2% | (5.54) |
| FY2019 | 15.7% | (0.87) |
| FY2018 | 16.6% | 5.62 |
| FY2017 | 10.9% | (2.02) |
| FY2016 | 13.0% | (0.32) |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| RMD ResMed Inc. compare | 19.3% |
| WST West Pharmaceutical Services, Inc. compare | 15.7% |
| ISRG Intuitive Surgical, Inc. | 15.3% |
| COO The Cooper Companies, Inc. compare | 4.55% |
| ALC Alcon compare | 2.06% |
| BDX Becton, Dickinson and Company compare | 1.78% |
| MDLN Medline Inc. compare | 1.49% |
| SOLV Solventum Corporation compare | 1.11% |
| BAX Baxter International Inc. compare | −3.57% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on ISRG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement